PTLA News and Press, Portola Pharmaceuticals Inc. From 01/10/20

Gainers:  Sorrento Therapeutics (NASDAQ: SRNE )  +38% . More news on: Sorrento Therapeutics, Inc., Ultragenyx Pharmaceutical Inc., Venus Concept Inc., Stocks on the move, Read more ...

Portola Pharmaceuticals (NASDAQ: PTLA )  -41%  on preliminary Q4 and FY 2019 results. More news on: Portola Pharmaceuticals, Inc., cbdMD, Inc., Naked Brand Group Limited, Stocks on the move, Read more ...

Aerie Pharmaceuticals (NASDAQ: AERI ) initiated with Neutral rating and $27 (6% upside) price target at Bank of America. More news on: Aurinia Pharmaceuticals Inc., BeyondSpring Inc., Cerecor Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Portola Pharmaceuticals (NASDAQ: PTLA ) slumps  39%  after hours in reaction to preliminary Q4 and 2019 results that are significantly below consensus. More news on: Portola Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Earnings news and commentary, Rea...

SOUTH SAN FRANCISCO, Calif. , Jan. 9, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced preliminary unaudited Andexxa global net revenues for the fourth quarter and full year 2019. For the fourth quarter, the Company expects Andexxa global net reven...

While small-cap stocks -- those with market caps between $500 million and $2 billion -- don't get as much attention as their large-cap cousins, there are plenty of promising investments in this area. Given their smaller sizer, these stocks have much more growth potential and are capable of multi...

Investing in the best growth stocks can generate superior returns over the long term. On the other hand, growth stocks are also particularly volatile and risky. The key, like usually happens, is separating the fundamentally sound companies from the ones with mediocre fundamentals. The follow...

SOUTH SAN FRANCISCO, Calif. , Dec. 23, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced that it will host an investor event to discuss expected corporate and product milestones in 2020. The event is scheduled to take place on Tuesday, January...

SOUTH SAN FRANCISCO, Calif. , Dec. 17, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced its support of the American Heart Association ® /American Stroke Association's ® newest initiative for enhanced awareness and understanding of b...

While the world of biotech has always been an interesting one, now's an especially exciting time to consider investing in the sector. There are many potential blockbuster drugs awaiting U.S. Food and Drug Administration (FDA) approval, with a number of treatments having already received a thum...